title: Fibrous intimal thickening at implantation as a risk factor for the outcome of cadaveric renal allografts.
abstract: BACKGROUND
  During the past decade, the donor age of cadaveric renal allografts steadily increased. Because cerebrovascular injury is the main cause of death in this donor population, an increased prevalence of atherosclerotic lesions in the retrieved grafts could be anticipated. In a prospective study, we investigated the predictive value of morphologic lesions at implantation for the functional and morphologic outcome of cadaveric renal allografts at 1 1/2 years.
  
  
  METHODS
  In 50 consecutive adult recipients of a cadaveric renal allograft, under cyclosporine-based regimen, implantation biopsies and subsequent protocol biopsies at 18 months were performed, and morphometrically analyzed for the extent of glomerulosclerosis, interstitial fibrosis, and atherosclerosis. Risk factors were assessed at implantation and during the subsequent observation period of 18 months. Endpoints for this study were: the 24-hr creatinine clearance (normalized for body surface area) and the fractional interstitial volume at 1 1/2 years.
  
  
  RESULTS
  In multivariate analysis, fibrous intimal thickening at implantation (FIT) was the main determinant of the functional and morphologic outcome at 1 1/2 years. FIT represented a relative risk of 4.55 for interstitial fibrosis (95% CI=1.855-11.138), and 1.89 for impaired renal function (95% CI=1.185-3.007) at 1 1/2 years. FIT adversely affected fractional interstitial volume at 1 1/2 years (34.3 vs. 27.7%, P=0.004), as well as renal function (54 vs. 68 ml/min/1.73 m2, P=0.028).
  
  
  CONCLUSIONS
  Fibrous intimal thickening at implantation is a determinant risk factor for the functional and morphologic outcome of cadaveric renal allografts at 1 1/2 years.
authors.affiliation: Department of Nephrology, University of Antwerp, Belgium.
authors.forename: J L
authors.initials: JL
authors.lastname: Bosmans
authors.forename: A
authors.initials: A
authors.lastname: Woestenburg
authors.forename: D K
authors.initials: DK
authors.lastname: Ysebaert
authors.forename: T
authors.initials: T
authors.lastname: Chapelle
authors.forename: M J
authors.initials: MJ
authors.lastname: Helbert
authors.forename: R
authors.initials: R
authors.lastname: Corthouts
authors.forename: A
authors.initials: A
authors.lastname: Jürgens
authors.forename: A
authors.initials: A
authors.lastname: Van Daele
authors.forename: E A
authors.initials: EA
authors.lastname: Van Marck
authors.forename: M E
authors.initials: ME
authors.lastname: De Broe
authors.forename: G A
authors.initials: GA
authors.lastname: Verpooten
mesh_terms: D000328:Adult; D002102:Cadaver; D005260:Female; D006801:Humans; D007668:Kidney / Q000473:pathology*; D016030:Kidney Transplantation; D008297:Male; D008875:Middle Aged; D011237:Predictive Value of Tests; D011446:Prospective Studies; D012079:Renal Circulation; D012307:Risk Factors; D014184:Transplantation, Homologous; D016896:Treatment Outcome; D017539:Tunica Intima / Q000473:pathology*